With questions, contact ACR RISE registry staff at [email protected] or 404-633-3777 x812 or contact the CMS Quality Payment Program at [email protected] or 1-866-288-8292.
Allison Plitman |
With questions, contact ACR RISE registry staff at [email protected] or 404-633-3777 x812 or contact the CMS Quality Payment Program at [email protected] or 1-866-288-8292.
The final rule, issued Nov. 2, finalizes many proposed policies, including a decreased conversion factor, billing for shared visits and teaching services, continuation of telehealth services and inclusion of an ACR-led Merit-Based Incentive Payment System Value Pathway.
The CMS has reopened the MIPS Extreme and Uncontrollable Circumstances applications for groups, virtual groups and Alternative Payment Model Entities are now open through March 31.
Many clinicians are receiving smaller reimbursements than expected for their 2021 Merit-Based Incentive Payment System adjustments. Available funding is extremely limited due to the high number of clinicians who were unable to report 2019 MIPS data and accepted the automatic neutral payment under the extreme and uncontrollable circumstances policy.
In November, the CMS finalized 12 MIPS Value Pathways (MVP) in the Quality Payment Program, including a rheumatology MVP. In 2023, clinicians can opt to report via traditional MIPS, the rheumatology MVP or both.